12:00 AM
 | 
Nov 23, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Hybrid Capture 2 High-Risk HPV DNA Test: Data

Data from a Finnish study in 108,425 women undergoing routine cervical cancer screening showed the Hybrid Capture 2 High-Risk HPV DNA Test with Pap smear test detected 44%, 39% and 22% more cases of cervical intraepithelial neoplasia grade 1 (CIN1), CIN2 and CIN3+, respectively,...

Read the full 199 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >